Elkfork Partners LLC - ARROWHEAD PHARMACEUTICALS IN ownership

ARROWHEAD PHARMACEUTICALS IN's ticker is ARWR and the CUSIP is 04280A100. A total of 229 filers reported holding ARROWHEAD PHARMACEUTICALS IN in Q3 2019. The put-call ratio across all filers is 1.54 and the average weighting 0.1%.

Quarter-by-quarter ownership
Elkfork Partners LLC ownership history of ARROWHEAD PHARMACEUTICALS IN
ValueSharesWeighting
Q3 2019$608,000
+74.7%
21,556
+64.2%
0.02%
+66.7%
Q2 2019$348,000
+728.6%
13,124
+467.6%
0.01%
+800.0%
Q1 2019$42,000
-87.3%
2,312
-91.3%
0.00%
-88.9%
Q4 2018$332,000
-48.7%
26,690
-20.9%
0.01%
-40.0%
Q3 2018$647,000
+257.5%
33,762
+154.0%
0.02%
+200.0%
Q2 2018$181,000
+82.8%
13,294
-2.7%
0.01%
+66.7%
Q1 2018$99,00013,6680.00%
Other shareholders
ARROWHEAD PHARMACEUTICALS IN shareholders Q3 2019
NameSharesValueWeighting ↓
WESTERN FINANCIAL Corp 820,264$54,392,00033.22%
Johnson & Johnson Innovation - JJDC, Inc. 3,260,869$216,228,00028.00%
L1 Capital Pty Ltd 296,024$19,629,0004.93%
Aquilo Capital Management, LLC 407,926$27,050,0004.89%
Evolutionary Tree Capital Management, LLC 72,948$4,837,0002.86%
ACUTA CAPITAL PARTNERS, LLC 108,000$7,161,0002.58%
First Light Asset Management, LLC 536,836$35,598,0002.36%
Parkman Healthcare Partners LLC 70,089$4,648,0001.08%
Hood River Capital Management LLC 357,082$23,678,0000.76%
Vanguard Capital Wealth Advisors 11,099$703,565,0000.60%
View complete list of ARROWHEAD PHARMACEUTICALS IN shareholders